动物免疫诊断市场规模、份额、成长分析、按产品、按技术、按动物类型、按疾病类型、按最终用户、按地区 - 行业预测，2025 年至 2032 年

2023 年全球兽医免疫诊断市场价值为 27 亿美元，预计将从 2024 年的 29.2 亿美元成长到 2032 年的 54.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.1%。

兽医免疫诊断市场正在经历强劲增长，这归因于多种因素，包括动物疾病的流行、疾病特异性免疫诊断测试的出现以及诊断技术的进步。宠物拥有量的快速增长以及对动物性食品的需求不断增长进一步推动了这种扩张。儘管发展中国家缺乏兽医诊断基础设施，但新兴经济体仍提供了巨大的成长机会。正在进行的 COVID-19 疫情提高了人类和动物的检测率，迫使实验室创新动物检测解决方案。儘管美国兽医协会和疾病预防控制中心等组织不建议对动物进行常规 COVID-19 检测，但卫生官员可能会根据不断变化的情况做出决定，这凸显了兽医和卫生官员之间合作的重要性。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

动物免疫诊断药物市场规模（按产品）

• 市场概况
• 耗材
• 装置

动物免疫诊断药物市场规模（依技术划分）

• 市场概况
• 临床生物化学
• 临床化学分析
• 临床化学试剂夹和试剂盒
• 临床化学分析仪
• 血糖监测
  • 血糖值测试纸
  • 血糖值监测仪
  • 尿糖测试纸
  • 血气和电解质分析
• 血气电解质试剂夹盒
  • 血糖值监测仪
• 血气电解质分析仪
• 分子诊断
  • 聚合酵素链锁反应（PCR）检测
  • 微阵列
  • 核酸序列分析
  • 其他分子诊断产品
• 血液学
  • 血液学试剂盒
  • 血液分析仪
• 尿液检查
  • 尿液检查夹和试剂盒/板
  • 尿液分析仪
  • 尿液检查
• 免疫诊断
  • 横向流动化验
  • 快速侧流检测
  • 横向流动试纸条读取器
  • ELISA 检测
  • 过敏特异性免疫诊断测试
  • 免疫检测分析仪
  • 免疫检测
  • 其他免疫诊断产品
• 其他兽医诊断技术

动物免疫诊断药物市场规模（以动物类型）

• 市场概况
• 伴同性动物
• 狗
• 猫
• 马
• 家畜
• 牛
• 猪
• 家禽
• 其他牲畜

动物免疫诊断药物市场规模（依疾病类型）

• 市场概况
• 感染疾病
• 细菌感染
• 病毒感染
• 寄生虫感染
• 其他感染疾病
• 内分泌系统
• 瘤
• 心臟病
• 其他的

动物免疫诊断药物市场规模（按最终用户划分）

• 市场概况
• 兽医参考实验室
• 兽医诊所
• 照护现场/内部侦测
• 兽医研究机构和大学

兽用免疫诊断药物市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• IDEXX Laboratories, Inc.（USA）
• Zoetis Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• bioMerieux SA（France）
• Heska Corporation（USA）
• NEOGEN Corporation（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Virbac（France）
• FUJIFILM Holdings Corporation（Japan）
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（China）
• INDICAL BIOSCIENCE GmbH（Germany）
• BioNote, Inc.（South Korea）
• Biogal Galed Labs（Israel）
• Agrolabo SpA（Italy）
• IDvet（France）
• Randox Laboratories Ltd.（UK）
• BioChek（Netherlands）
• Biopanda Reagents（UK）
• URIT Medical Electronic Co., Ltd.（China）
• Bionote, Inc.（South Korea）

结论和建议

Global Veterinary Immunodiagnostics Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.92 billion in 2024 to USD 5.44 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The veterinary immunodiagnostics market is experiencing robust growth driven by several factors, including the increased prevalence of animal diseases, the advent of disease-specific immunodiagnostic tests, and advancements in diagnostic technology. A surge in pet ownership and rising demand for animal-derived food products further fuel this expansion. Emerging economies present significant growth opportunities, despite challenges posed by inadequate veterinary diagnostic infrastructure in developing regions. The ongoing COVID-19 pandemic has heightened testing rates for both humans and animals, compelling laboratories to innovate animal testing solutions. Although organizations like the AVMA and CDC do not endorse routine COVID-19 testing for animals, the decision may be prompted by health officials based on evolving circumstances, underscoring the importance of collaboration between veterinarians and health authorities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Immunodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Immunodiagnostics Market Segmental Analysis

Global Veterinary Immunodiagnostics Market is segmented by Product, Technology, Animal Type, Disease Type, End User and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Immunodiagnostics and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals and Livestock. Based on Disease Type, the market is segmented into Infectious Disease, Endocrinology, Oncology, Cardiology and Others. Based on End User, the market is segmented into Veterinary Reference Laboratories, Veterinary Hospitals & Clinics, Point-of-care/ In-house Testing and Veterinary Research Institutes & Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market is significantly driven by the potential transmission of serious zoonotic illnesses from animals to humans. At least 30 major diseases, including rabies, leptospirosis, and zoonotic tuberculosis, can spread through livestock and companion animals such as dogs and cats. The increasing prevalence of transboundary diseases, exemplified by foot-and-mouth disease affecting a large portion of livestock globally, further underscores the need for effective immunodiagnostic tools. Additionally, the emergence of zoonotic sources such as those linked to the COVID-19 pandemic highlights the critical role veterinary diagnostics play in safeguarding public health and preventing future outbreaks, ultimately fostering market growth.

Restraints in the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market faces significant restraints due to the rising costs associated with pet care over the last decade. Research indicates that veterinary care represents the second-largest spending category within the pet care industry, with the U.S. alone contributing over $18.11 billion, marking a 6.1% increase from the previous year. High-end veterinary procedures can range from $5,000 to $20,000, while typical diagnostic costs for assessing antimicrobial resistance or infections using advanced techniques like PCR are notably steep. The reliance on expensive materials and cutting-edge technologies for treatments makes pet owners and veterinarians reluctant to invest heavily in diagnostic services.

Market Trends of the Global Veterinary Immunodiagnostics Market

The Global Veterinary Immunodiagnostics market is poised for significant growth, driven by the rising prevalence of zoonotic and vector-borne diseases linked to climate change, habitat modification, and evolving social dynamics. As these diseases become more common, there is an increasing need for rapid and precise diagnostic tools, particularly in companion animal medicine in developed countries. This trend is further fueled by a growing preference for advanced diagnostic technologies, such as RT-PCR, over traditional methods. Consequently, veterinary immunodiagnostics will play a critical role in disease management and prevention, positioning itself as a vital segment within the broader veterinary diagnostics market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Veterinary Immunodiagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
• Instruments

Global Veterinary Immunodiagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Clinical Biochemistry
• Clinical Chemistry Analysis
• Clinical Chemistry Reagent Clips & Cartridges
• Clinical Chemistry Analyzers
• Glucose Monitoring
  • Blood Glucose Strips
  • Glucose Monitors
  • Urine Glucose Strips
  • Blood Gas & Electrolyte Analysis
• Blood Gas And Electrolyte Reagent Clips and Cartridges
  • Glucose Monitors
• Blood Gas & Electrolyte Analyzers
• Molecular Diagnostics
  • Ploymerase Chain Reaction (PCR) Tests
  • Microarrays
  • Nucleic Acid Sequencing
  • Other Molecular Diagnostic Products
• Hematology
  • Hematology Cartridges
  • Hematology Analyzers
• Urinalysis
  • Urinalysis Clips & Cartridges/Panels
  • Urine Analyzers
  • Urine Test Strips
• immunodiagnostics
  • Lateral Flow Assays
  • Lateral Flow Rapid Tests
  • Lateral Flow Strip Readers
  • ELISA Tests
  • Allergen-specific Immunodiagnostic Tests
  • Immunoassay Analyzers
  • Radioimmunoassay
  • Other Immunodiagnostic Products
• Other Veterinary Diagnostic Technologies

Global Veterinary Immunodiagnostics Market Size by Animal Type & CAGR (2025-2032)

• Market Overview
• Companion Animals
• Dogs
• Cats
• Horses
  • Other Companion Animals
• Livestock
• Cattle
• Pigs
• Poultry
• Other Livestock

Global Veterinary Immunodiagnostics Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Infectious Disease
• Bacterial Infection
• Viral Infection
• Parasitic Infection
• Other Infection
• Endocrinology
• Oncology
• Cardiology
• Others

Global Veterinary Immunodiagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Veterinary Reference Laboratories
• Veterinary Hospitals & Clinics
• Point-of-care/ In-house Testing
• Veterinary Research Institutes & Universities

Global Veterinary Immunodiagnostics Market Size & CAGR (2025-2032)

• North America (Product, Technology, Animal Type, Disease Type, End User)
  • US
  • Canada
• Europe (Product, Technology, Animal Type, Disease Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Animal Type, Disease Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Animal Type, Disease Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Animal Type, Disease Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IDEXX Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• INDICAL BIOSCIENCE GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNote, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogal Galed Labs (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrolabo S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDvet (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioChek (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopanda Reagents (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• URIT Medical Electronic Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionote, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations